Bolt Biotherapeutics has halved…
Bolt Biotherapeutics has halved its workforce for the second time [...]
Bolt Biotherapeutics has halved its workforce for the second time [...]
Takeda is tapping out of the cell therapy arena as [...]
After axing billions in biomedical research grants and pulling the [...]
The FDA issued a complete response letter in response to [...]
Japanese biotech Heartseed said it was “difficult to reasonably foresee” [...]
U.S.-based Barinthus Biotherapeutics is entering a reverse merger with U.K. [...]
AnaptysBio plans to split into two publicly traded companies, with [...]
After Harvard University scored a recent legal victory over the [...]
Israeli drug developer BioLineRx is heading north to help Norwegian [...]
Applied Therapeutics is providing an unusual non-update, announcing that the [...]